0001209191-23-036624.txt : 20230613
0001209191-23-036624.hdr.sgml : 20230613
20230613160122
ACCESSION NUMBER: 0001209191-23-036624
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230612
FILED AS OF DATE: 20230613
DATE AS OF CHANGE: 20230613
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Legorreta Pablo G.
CENTRAL INDEX KEY: 0001507678
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39329
FILM NUMBER: 231011243
MAIL ADDRESS:
STREET 1: 110 E 59TH STREET
STREET 2: SUITE 3300
CITY: NEW YORK
STATE: NY
ZIP: 10022
FORMER NAME:
FORMER CONFORMED NAME: Legorreta Pablo
DATE OF NAME CHANGE: 20101213
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Royalty Pharma plc
CENTRAL INDEX KEY: 0001802768
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: X0
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 110 EAST 59TH STREET
CITY: NEW YORK
STATE: NY
ZIP: 10022
BUSINESS PHONE: (212) 883-0200
MAIL ADDRESS:
STREET 1: 110 EAST 59TH STREET
CITY: NEW YORK
STATE: NY
ZIP: 10022
4
1
doc4.xml
FORM 4 SUBMISSION
X0407
4
2023-06-12
0
0001802768
Royalty Pharma plc
RPRX
0001507678
Legorreta Pablo G.
C/O ROYALTY PHARMA PLC
110 E. 59TH STREET
NEW YORK
NY
10022
1
1
1
0
CEO, Chairman of the Board
0
Class A ordinary shares
2023-06-12
4
P
0
45000
32.9988
A
425000
I
By Legorreta 2023 SR Trust
Class A ordinary shares
2023-06-13
4
P
0
45000
32.7756
A
470000
I
By Legorreta 2023 SR Trust
Class A ordinary shares
63795
D
Class A ordinary shares
460139
I
By Legorreta Investments LLC
Class A ordinary shares
1284590
I
By GST-Exempt Legorreta 2012 Family Trust
Class A ordinary shares
41306
I
By GST-Exempt Legorreta 2020 Family Trust
Class A ordinary shares
10000
I
By Child
Class A ordinary shares
10000
I
By Child
Class A ordinary shares
123310
I
By IRRA
Class A ordinary shares
118500
I
By SEP/IRA
Class A ordinary shares
1040410
I
By Legorreta Children 2002 Trust
Class A ordinary shares
6930
I
By Spouse
Represents shares acquired by the reporting person in open market transactions as part of the reporting person's previously disclosed intention to purchase up to $50 million of the issuer's Class A ordinary shares, as announced in the issuer's press release on March 27, 2023 regarding the issuer's $1.0 billion share repurchase program.
The price reported in Column 4 is a weighted average price. The reported securities were purchased in multiple transactions at prices ranging from $32.97 to $33.00. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within such range.
The price reported in Column 4 is a weighted average price. The reported securities were purchased in multiple transactions at prices ranging from $32.66 to $32.80. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within such range.
/s/ Sean Weisberg, as Attorney-in-Fact for Pablo G. Legorreta
2023-06-13